|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-9-30
|
|
pubmed:abstractText |
Immune reconstitution in highly active antiretroviral therapy (HAART)-treated individuals is incomplete and immunomodulatory compounds are needed to improve the outcome of HIV therapy. In a Phase I/II clinical trial performed on HIV-positive patients we analysed the safety and immunomodulating effects of tucaresol, a novel compound that has previously been described tn enhance cell-mediated immune responses.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
pubmed-author:BanderaAlessandraA,
pubmed-author:BiasinMaraM,
pubmed-author:BrayDorothyD,
pubmed-author:ClericiMarioM,
pubmed-author:FerrantePasqualeP,
pubmed-author:FranzettiFabioF,
pubmed-author:GalliMassimoM,
pubmed-author:GazzolaLidiaL,
pubmed-author:GoriAndreaA,
pubmed-author:MarchettiGiuliaG,
pubmed-author:McDadeHughH,
pubmed-author:MoroniMauroM,
pubmed-author:PanebiancoRuggeroR,
pubmed-author:RhodesJohnJ,
pubmed-author:SaresellaMarinaM,
pubmed-author:ThomasNicolaN,
pubmed-author:TrabattoniDariaD
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
603-14
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15456092-Adult,
pubmed-meshheading:15456092-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15456092-Benzaldehydes,
pubmed-meshheading:15456092-Benzoates,
pubmed-meshheading:15456092-Female,
pubmed-meshheading:15456092-HIV Infections,
pubmed-meshheading:15456092-HIV-1,
pubmed-meshheading:15456092-Humans,
pubmed-meshheading:15456092-Immunologic Factors,
pubmed-meshheading:15456092-Lymphocyte Count,
pubmed-meshheading:15456092-Male,
pubmed-meshheading:15456092-Middle Aged,
pubmed-meshheading:15456092-Pilot Projects,
pubmed-meshheading:15456092-Pulse Therapy, Drug,
pubmed-meshheading:15456092-RNA, Viral,
pubmed-meshheading:15456092-T-Lymphocyte Subsets,
pubmed-meshheading:15456092-T-Lymphocytes, Cytotoxic
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial.
|
|
pubmed:affiliation |
Institute of Infectious Diseases and Tropical Medicine, 'L Sacco' Hospital, University of Milan, Milan, Italy. andrea.gori@unimi.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
